Effect of the Consumption of Alcohol-free Beers With Different Carbohydrates Composition on Postprandial Metabolic Response
- Conditions
- Healthy DietPostprandial Hyperglycemia
- Interventions
- Other: Sub-study 1Other: Sub-study 2
- Registration Number
- NCT04790877
- Lead Sponsor
- Universidad de Zaragoza
- Brief Summary
The overall objective of this study is to explore the glycemic index and glycemic load induced by an alcohol-free beer with modified composition (including almost full fermentation of carbohydrates and the addition of isomaltulose and a resistant maltodextrin), as well as its postprandial metabolic response, compared to the effect induced by: a) an alcohol-free beer with a usual composition; b) an alcohol-free beer with modified composition (including almost full fermentation of carbohydrates and the addition of a resistant maltodextrin). This study includes two cross-over sub-studies recruiting healthy participants. In the first one, 10 healthy volunteers receive 25 g of carbohydrates coming from: regular alcohol-free beer (RB), alcohol-free beer with almost completely eliminated maltose and enriched with isomaltulose (2.5 g/100 mL) and a resistant maltodextrin (0.8 g/100 mL) (IMB), alcohol-free beer with the same maltose removal enriched with resistant maltodextrin (2.0 g/100 mL) (MB) and glucose solution. In the second study, 20 healthy volunteers are provided with 50 g of carbohydrates from white bread and water and the same meal plus 14.3 g of carbohydrates coming from: RB, IMB, MB and extra white bread. Blood is sampled at baseline and for 2 h, every 15 min, after ingestion.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 30
- BMI between 18.5 and 27.5 kg/m2.
- Presence of cardiometabolic pathology such as dyslipemia (total cholesterol > 200 mg/dL and/or triglycerides > 150 mg/dL, and/or taking lipid-lowering drugs), prediabetes or type 1 or 2 diabetes mellitus (glucose ≥ 100 mg/dL and/or glycosylated hemoglobin ≥ 5.7% and/or taking hypoglycemic drugs) or high blood pressure without drug treatment.
- Presence of other chronic pathologies that could interfere with the results of the study such as cardiovascular disease, kidney disease, thyroid disease or liver disease.
- Presence of intestinal malabsorption syndromes and/or presence of Chron disease or ulcerative colitis.
- Use of drugs that may interfere with lipid and/or glycidic metabolism.
- Presence of some analytical alteration that could interfere with the results of the study.
- Increased or decreased body weight of ≥ 5 kg in the last 6 months.
- Gluten intolerance.
- Regular intake of functional foods such as phytosterols or red rice yeast, which have a significant effect on lipid or glycidic metabolism, in the last 6 weeks.
- Intake of vitamin supplements.
- Hormone replacement therapy.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description First sub-study: Alcohol-free beer with modified composition (isomaltulose + maltodextrin) Sub-study 1 This intervention entails the intake of an alcohol-free beer with modified composition in which the maltose has been almost completely eliminated and enriched with isomaltulose (2.5 g/100 mL) and a resistant maltodextrin (0.8 g/100 mL) (IMB). This beverage included 25 g of carbohydrates. Second sub-study: White bread + Water Sub-study 2 This intervention entails the intake of white bread (providing 50 g of carbohydrates) and water. First sub-study: Glucose beverage Sub-study 1 This intervention entails the intake of a beverage including 25 g of glucose. Second sub-study: White bread+Alcohol-free beer enriched with isomaltulose+maltodextrin) Sub-study 2 This intervention entails the intake of white bread (providing 50 g of carbohydrates) and an alcohol-free beer with modified composition in which the maltose has been almost completely eliminated and enriched with isomaltulose (2.5 g/100 mL) and a resistant maltodextrin (0.8 g/100 mL) (IMB). This beverage included 14.3 g of carbohydrates. First sub-study: Regular alcohol-free beer Sub-study 1 This intervention entails the intake of regular alcohol-free beer including 25 of carbohydrates. First sub-study: Alcohol-free beer with modified composition (++ maltodextrin) Sub-study 1 This intervention entails the intake of an alcohol-free beer with modified composition in which the maltose has been almost completely eliminated and enriched with a resistant maltodextrin (2.0 g/100 mL) (MB). This beverage included 25 g of carbohydrates. Second sub-study: White bread + Alcohol-free beer enriched with ++ maltodextrin Sub-study 2 This intervention entails the intake of white bread (providing 50 g of carbohydrates) and an alcohol-free beer with modified composition in which the maltose has been almost completely eliminated and enriched a resistant maltodextrin (2.0 g/100 mL) (MB). This beverage included 14.3 g of carbohydrates. Second sub-study: White bread + Regular alcohol-free beer Sub-study 2 This intervention entails the intake of white bread (providing 50 g of carbohydrates) and regular alcohol-free beer (providing 14.3 g of carbohydrates). Second sub-study: Extra-White bread + Water Sub-study 2 This intervention entails the intake of white bread which provides 64.3 g (50 g + 14.3 g) of carbohydrates and water. This intervention would be the comparator in carbohydrates-equally conditions.
- Primary Outcome Measures
Name Time Method Glucose Change from Baseline to 120-minutes after consumption of the beverage. GLP-1 Change from Baseline to 120-minutes after consumption of the beverage. GIP Change from Baseline to 120-minutes after consumption of the beverage. Insulin Change from Baseline to 120-minutes after consumption of the beverage.
- Secondary Outcome Measures
Name Time Method Pancreatic polypeptide Change from Baseline to 120-minutes after consumption of the beverage. LDL cholesterol Change from Baseline to 120-minutes after consumption of the beverage. Leptin Change from Baseline to 120-minutes after consumption of the beverage. Polypeptide Y Change from Baseline to 120-minutes after consumption of the beverage. Triglycerides Change from Baseline to 120-minutes after consumption of the beverage. Glucagon Change from Baseline to 120-minutes after consumption of the beverage. Ghrelin Change from Baseline to 120-minutes after consumption of the beverage. HDL cholesterol Change from Baseline to 120-minutes after consumption of the beverage.
Trial Locations
- Locations (1)
Instituto de Investigación Sanitaria Aragón, Hospital Universitario Miguel Servet, Universidad de Zaragoza
🇪🇸Zaragoza, Spain